In the light of our observation of the therapeutic potential of Loxoribin in colon cancer and lung cancer, TLR7 therapy may be important for human cancer, and TLR7 ligands and their analogs could be immunotherapeutic modalities in cancer patients in the future. This evidence concerns the gene TLR7 and malignant colon neoplasm.